Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;29(6):1775-1783.
doi: 10.1007/s10461-025-04646-6. Epub 2025 Feb 3.

PrEP Awareness, Interest, and Use among Women Who Inject Drugs in Seattle, Washington: A Mixed Methods Study

Affiliations

PrEP Awareness, Interest, and Use among Women Who Inject Drugs in Seattle, Washington: A Mixed Methods Study

Lauren R Violette et al. AIDS Behav. 2025 Jun.

Abstract

Women who inject drugs (WWID) are disproportionately affected by HIV and experience multiple barriers to PrEP use. We conducted a mixed methods study to assess PrEP awareness, interest, and use, and determinants of PrEP utilization among WWID at three community sites in Seattle, Washington from March-May 2023. Participants were ≥ 18 years old, spoke English, identified as women, had a history of injecting drugs, and self-reported a negative or unknown HIV status. We describe survey participant characteristics (n = 30) by PrEP candidacy based on behaviors associated with HIV acquisition. We concurrently recruited 16 WWID for semi-structured interviews, which were analyzed using the Rapid Assessment Process. Survey and interview data were triangulated to enhance interpretations. Among 30 WWID, 25 (83%) were PrEP candidates, of whom 19 (76%) had heard about PrEP; only 2 (8%) were currently using PrEP. Among PrEP candidates, 13 (57%) reported interest in daily oral PrEP and almost half (n = 12, 48%) reported interest in injectable PrEP. Qualitative data revealed cursory PrEP knowledge and a strong interest in daily oral and injectable PrEP among those who perceived they were at risk for HIV. Several barriers to PrEP use were noted including housing instability, adherence challenges, limited perceived risk, and competing priorities like safety and substance use. While most WWID were aware of PrEP, qualitative data suggested significant misconceptions about PrEP, and many described complex, intersecting barriers to use. Our findings highlight the need for increased low-barrier, population-specific interventions to improve uptake and sustained use of PrEP among WWID.

Keywords: HIV; Injection drug use; PrEP; Transactional sex; Women.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: The authors have no competing interests to declare that are relevant to the content of this article.

Similar articles

Cited by

References

    1. Injection drug use. HIV. Centers for Disease Control and Prevention, March 16, 2022. Available at: https://www.cdc.gov/hiv/risk/drugs/index.html
    1. Des Jarlais DC, McKnight C, Feelemyer J, et al. Heterosexual male and female disparities in HIV infection at the end of an epidemic: HIV infection among persons who inject drugs in New York City, 2001–2005 and 2011–2015. Drug Alcohol Depend 2018;185:391–397. doi: 10.1016/j.drugalcdep.2017.12.039. - DOI - PMC - PubMed
    1. Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend 2012;124(1–2):95–107. doi: 10.1016/j.drugalcdep.2011.12.020. - DOI - PMC - PubMed
    1. Syvertsen JL, Robertson AM, Strathdee SA, et al. Rethinking risk: Gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico–US border. Int J Drug Policy. 2014;25(5):836–44. doi: 10.1016/j.drugpo.2014.02.005. - DOI - PMC - PubMed
    1. Strathdee SA, West BS, Reed E, et al. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr 2015;69 Suppl 2(0 1):S110–7. doi: 10.1097/QAI.0000000000000624. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources